Characteristic | % | (n/N) |
---|---|---|
Use of IPTp-SP | Â | Â |
None | 21.4 | (79/370)* |
At least one | 78.7 | (291/370)* |
At least two | 26.9 | (46/171)** |
Gestational age at 1st IPTp-SP dose | Â | Â |
   <20 week | 4.7 | (14/299) |
   20-24 weeks | 72.9 | (218/299) |
   >24 weeks | 22.4 | (67/299) |
Gestational age at 2nd IPTp-SP dose | Â | Â |
   <28 weeks | 11.8 | (6/51) |
   28-32 weeks | 84.3 | (43/51) |
   >32 weeks | 3.9 | (2/51) |